FDA will not subject device data systems to premarket approval

02/14/2011 | Health Data Management

The FDA is set to unveil today the final rule that would exempt medical device data systems from premarket approval by reclassifying such devices from the Class III category to Class I. In its final rule, the agency discussed the functions of an MDDS and stated the differences between an MDDS and a patient monitoring system.

View Full Article in:

Health Data Management

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC